893 related articles for article (PubMed ID: 28105473)
1. Recent applications of the combination of mesoporous silica nanoparticles with nucleic acids: development of bioresponsive devices, carriers and sensors.
Castillo RR; Baeza A; Vallet-Regí M
Biomater Sci; 2017 Feb; 5(3):353-377. PubMed ID: 28105473
[TBL] [Abstract][Full Text] [Related]
2. Shape matters when engineering mesoporous silica-based nanomedicines.
Hao N; Li L; Tang F
Biomater Sci; 2016 Apr; 4(4):575-91. PubMed ID: 26818852
[TBL] [Abstract][Full Text] [Related]
3. Mesoporous silica nanoparticles for intracellular controlled drug delivery.
Vivero-Escoto JL; Slowing II; Trewyn BG; Lin VS
Small; 2010 Sep; 6(18):1952-67. PubMed ID: 20690133
[TBL] [Abstract][Full Text] [Related]
4. Mesoporous Silica Nanoparticles Decorated with Carbosilane Dendrons as New Non-viral Oligonucleotide Delivery Carriers.
Martínez Á; Fuentes-Paniagua E; Baeza A; Sánchez-Nieves J; Cicuéndez M; Gómez R; de la Mata FJ; González B; Vallet-Regí M
Chemistry; 2015 Oct; 21(44):15651-66. PubMed ID: 26361378
[TBL] [Abstract][Full Text] [Related]
5. Mesoporous silica nanoparticles for therapeutic/diagnostic applications.
Jafari S; Derakhshankhah H; Alaei L; Fattahi A; Varnamkhasti BS; Saboury AA
Biomed Pharmacother; 2019 Jan; 109():1100-1111. PubMed ID: 30551360
[TBL] [Abstract][Full Text] [Related]
6. Polyvalent nucleic acid/mesoporous silica nanoparticle conjugates: dual stimuli-responsive vehicles for intracellular drug delivery.
Chen C; Geng J; Pu F; Yang X; Ren J; Qu X
Angew Chem Int Ed Engl; 2011 Jan; 50(4):882-6. PubMed ID: 21246683
[No Abstract] [Full Text] [Related]
7. Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers.
Slowing II; Vivero-Escoto JL; Wu CW; Lin VS
Adv Drug Deliv Rev; 2008 Aug; 60(11):1278-1288. PubMed ID: 18514969
[TBL] [Abstract][Full Text] [Related]
8. Mesoporous Silica and Organosilica Nanoparticles: Physical Chemistry, Biosafety, Delivery Strategies, and Biomedical Applications.
Croissant JG; Fatieiev Y; Almalik A; Khashab NM
Adv Healthc Mater; 2018 Feb; 7(4):. PubMed ID: 29193848
[TBL] [Abstract][Full Text] [Related]
9. Functionalized mesoporous silica particles for application in drug delivery system.
Pang J; Luan Y; Yang X; Jiang Y; Zhao L; Zong Y; Li Z
Mini Rev Med Chem; 2012 Jul; 12(8):775-88. PubMed ID: 22512562
[TBL] [Abstract][Full Text] [Related]
10. Mesoporous silica nanoparticles: synthesis, biocompatibility and drug delivery.
Tang F; Li L; Chen D
Adv Mater; 2012 Mar; 24(12):1504-34. PubMed ID: 22378538
[TBL] [Abstract][Full Text] [Related]
11. Mesoporous silica nanoparticles with organo-bridged silsesquioxane framework as innovative platforms for bioimaging and therapeutic agent delivery.
Du X; Li X; Xiong L; Zhang X; Kleitz F; Qiao SZ
Biomaterials; 2016 Jun; 91():90-127. PubMed ID: 27017579
[TBL] [Abstract][Full Text] [Related]
12. Mesoporous-Silica-Functionalized Nanoparticles for Drug Delivery.
Giret S; Wong Chi Man M; Carcel C
Chemistry; 2015 Sep; 21(40):13850-65. PubMed ID: 26250991
[TBL] [Abstract][Full Text] [Related]
13. Poly-L-lysine functionalized large pore cubic mesostructured silica nanoparticles as biocompatible carriers for gene delivery.
Hartono SB; Gu W; Kleitz F; Liu J; He L; Middelberg AP; Yu C; Lu GQ; Qiao SZ
ACS Nano; 2012 Mar; 6(3):2104-17. PubMed ID: 22385282
[TBL] [Abstract][Full Text] [Related]
14. Large pore mesoporous silica nanomaterials for application in delivery of biomolecules.
Knežević NŽ; Durand JO
Nanoscale; 2015 Feb; 7(6):2199-209. PubMed ID: 25583539
[TBL] [Abstract][Full Text] [Related]
15. Mesoporous silica nanoparticles as cutting-edge theranostics: Advancement from merely a carrier to tailor-made smart delivery platform.
Kumar P; Tambe P; Paknikar KM; Gajbhiye V
J Control Release; 2018 Oct; 287():35-57. PubMed ID: 30125637
[TBL] [Abstract][Full Text] [Related]
16. Silicon-polymer hybrid materials for drug delivery.
McInnes SJ; Voelcker NH
Future Med Chem; 2009 Sep; 1(6):1051-74. PubMed ID: 21425994
[TBL] [Abstract][Full Text] [Related]
17. Biocompatibility of mesoporous silica nanoparticles.
Asefa T; Tao Z
Chem Res Toxicol; 2012 Nov; 25(11):2265-84. PubMed ID: 22823891
[TBL] [Abstract][Full Text] [Related]
18. Rod-shaped mesoporous silica nanoparticles for nanomedicine: recent progress and perspectives.
Cong VT; Gaus K; Tilley RD; Gooding JJ
Expert Opin Drug Deliv; 2018 Sep; 15(9):881-892. PubMed ID: 30173560
[TBL] [Abstract][Full Text] [Related]
19. Advances in Peptide Functionalization on Mesoporous Silica Nanoparticles for Controlled Drug Release.
Hu JJ; Xiao D; Zhang XZ
Small; 2016 Jul; 12(25):3344-59. PubMed ID: 27152737
[TBL] [Abstract][Full Text] [Related]
20. Mesoporous Silica Nanoparticles as Carriers for Intracellular Delivery of Nucleic Acids and Subsequent Therapeutic Applications.
Cha W; Fan R; Miao Y; Zhou Y; Qin C; Shan X; Wan X; Li J
Molecules; 2017 May; 22(5):. PubMed ID: 28492505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
